{"version":"1.0","type":"link","title":"Neoadjuvant modified FOLFIRINOX plus nivolumab in borderline-resectable pancreatic ductal adenocarcinoma: a pilot phase 1 trial.","author_name":"Wainberg ZA 외","author_url":"https://prs-insight.online/author/Wainberg%20ZA","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/168734","thumbnail_width":1200,"thumbnail_height":630}